Agenus Inc

AGENNASDAQ · USD
5.97USD0.00 (-2.77%)
5210

Agenus Inc (AGEN) Straddle

AGEN straddle scan found 31 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 57.9%.

Read more

Trading a AGEN straddle lets you take a pure volatility position on Agenus Inc without committing to a direction. Agenus Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate AGEN straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on AGEN profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Agenus Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the AGEN straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer; AGEN1181, an anti-CTLA-4 monospecific antibody that is in Phase 1/2 clinical trial; AGEN2373, an anti-CD137 monospecific antibody that is in Phase 1 clinical trial; AGEN1423, a tumor microenvironment conditioning anti-CD73/TGFß TRAP bi-functional antibody that has completed Phase 1 clinical trial; AGEN1777, an anti-TIGIT bispecific antibodies; and AGEN1327, a human monoclonal antibody.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the AGEN straddle is the cleanest expression of that view. Our scanner prices every AGEN straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a AGEN straddle into a catalyst or short a AGEN straddle to harvest decay, the options straddle setups that matter are all in one place.

May 21, 202717.00$11.131832%57.9%$28.13$5.880
May 21, 202711.00$5.701832%53.5%$16.70$5.300
Jan 21, 202812.00$8.054282%51.5%$20.05$3.950
Jan 19, 202917.00$14.157922%50.7%$31.15$2.850
Jan 21, 202815.00$11.054282%49.4%$26.05$3.950
Feb 19, 202710.00$4.50922%48.5%$14.50$5.500
Jan 19, 202915.00$12.507922%47.3%$27.50$2.502
Jan 21, 202817.00$13.204282%46.9%$30.20$3.800
May 21, 202710.00$5.301832%46.5%$15.30$4.700
Feb 19, 20278.00$3.00922%44.3%$11.00$5.001

As of Nov 19, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →